Like his Big Pharma peers, Pfizer (PFE) CEO Albert Bourla is waiting for the US government to finalize its decision on whether to place a 25% tariff on pharmaceutical imports. To be sure ...

Matthew Herper covers medical innovation — both its promise and its perils. Capping more than two years of stock-gyrating drama, Pfizer said Monday that it would stop development of danuglipron ...

In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other blue chip stocks to invest in at 52-week lows. For the first time since 2023, the S&P 500 was seen ...

Pfizer shares fell 1.32% after reports U.S. prosecutors are investigating claims from GSK about the timing of Pfizer’s COVID-19 vaccine. Pfizer denies allegations of delaying vaccine results for ...

54. It’s only February, but my pick for the Worst Biopharma CEO of 2025 has already been decided: Albert Bourla of Pfizer. Pfizer’s decision to hire Patrizia Cavazzoni, a former top drug ...

Genotropin (somatropin) is a brand-name injectable solution used for growth problems in certain adults and children. As with other drugs, Genotropin can cause side effects, such as injection site ...

Genotropin comes in two forms: a single-use Mini-Quick device and multiuse pens. Both are used to administer the drug as an injection under the skin. Keep reading to learn about common ...

It’s available as a cartridge that’s attached to a reusable pen and ... purplebooksearch.fda.gov Genotropin (somatropin) for injection, for subcutaneous use. (2019). https://labeling.pfizer ...

We recently compiled a list of the 10 Worst Performing Blue Chip Stocks in 2024. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other worst ...

Genotropin is available as multiuse pens or single-use Mini-Quick devices. Your doctor will choose the form of Genotropin that is best for you. Both forms of Genotropin should be stored in the ...

Pfizer has agreed to settle more than 10,000 lawsuits which alleged that the company failed to warn patients about possible cancer risks caused by the anti-heartburn medication Zantac. The ...

Miller previously led negotiations for Blue Buffalo's $8 billion sale to General Mills. He was also a senior corporate counsel at Pfizer, where he headed legal for two critical business units.